Question 560
In a discussion with the delivery team on an adaptive/agile initiative, a pharmaceutical research project plans to use a consent form that predates the new data reuse purpose. Which indicator would most directly show whether this specific situation is improving?
Explanation
Correct Answer
Track research records lacking valid authorization for the new purpose. The indicator reflects the underlying outcome or remaining exposure rather than a nearby but different activity. In this case, an existing consent cannot automatically support a materially new purpose. The stated constraint is: A pharmaceutical research project plans to use a consent form that predates the new data reuse purpose. The chosen measurement is the most direct response under these conditions.
Incorrect Answers
Track workers assigned hazardous tasks without valid training evidence. This response addresses another situation in the same task area: A predictive construction project discovers new worker safety training requirements midway through excavation. There, regulatory compliance must be demonstrated at the point of exposure. For the current situation—A pharmaceutical research project plans to use a consent form that predates the new data reuse purpose—this option would leave the specific need unresolved: an existing consent cannot automatically support a materially new purpose.
Track material unreported emissions sources by reporting period. This response addresses another situation in the same task area: A city procurement program discovers that a contractor's emissions report omits subcontractor equipment. There, environmental claims require full boundary coverage, not a selective vendor summary. For the current situation—A pharmaceutical research project plans to use a consent form that predates the new data reuse purpose—this option would leave the specific need unresolved: an existing consent cannot automatically support a materially new purpose.
Track open accessibility failures preventing authorized occupancy. This response addresses another situation in the same task area: A global construction contract requires accessibility audits that the final acceptance checklist omits. There, omitting a compliance control from the checklist does not remove the obligation. For the current situation—A pharmaceutical research project plans to use a consent form that predates the new data reuse purpose—this option would leave the specific need unresolved: an existing consent cannot automatically support a materially new purpose.